The University of Birmingham has received the ‘UK Research Paper of the Year’ award for its research paper on the results from BUMPES trial, at The BMJ Awards 2018.

The randomised, controlled BUMPES trial was conducted to investigate the most ideal position for a first-time mother, administered with low dose epidural, to improve the chance of a birth without interventions such as forceps or caesarean.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
“The researchers concluded that adopting a lying down on their side position, instead of being upright, during the later stages of labour provides a higher chance of delivery without medical intervention.”

The trial enrolled 3,093 women across 41 UK hospitals between October 2010 and January 2014. It was funded by the National Institute for Health Research.

Based on the findings, the researchers concluded that adopting a lying down on their side position, instead of being upright, during the later stages of labour provides a higher chance of delivery without medical intervention.

University of Birmingham, Birmingham Clinical Trials Unit director Peter Brocklehurst said: “This study shows there are simple things we can do which can improve outcomes for women and their babies.

“Adopting this practice into routine clinical care for these women will be easy and will mean tens of thousands of women and babies in the UK, and hundreds of thousands of women and babies in the world, will be able to have a straightforward birth without the need for forceps, vacuum or Caesarean section.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Another research paper authored by the university on the STAMPEDE trial results was also short-listed for the BMJ Awards 2018.

Funded by the Cancer Research UK, the STAMPEDE trial indicated that addition of abiraterone drug to hormone therapy at the beginning of treatment improves survival in prostate cancer patients by 37%.